Dmitri Sviridov1, Michael Bukrinsky. 1. aBaker IDI Heart and Diabetes Institute, Melbourne, Australia bGeorge Washington University School of Medicine and Health Sciences, Washington, DC, USA.
Abstract
PURPOSE OF REVIEW: Pathogens of different taxa, from prions to protozoa, target cellular cholesterol metabolism to advance their own development and to impair host immune responses, but also causing metabolic complications, for example, atherosclerosis. This review describes recent findings of how pathogens do it. RECENT FINDINGS: A common theme in interaction between pathogens and host cholesterol metabolism is pathogens targeting lipid rafts of the host plasma membrane. Many intracellular pathogens use rafts as an entry gate, taking advantage of the endocytic machinery and high abundance of outward-looking molecules that can be used as receptors. At the same time, disruption of the rafts' functional capacity, achieved by the pathogens through a number of various means, impairs the ability of the host to generate immune response, thus helping pathogen to thrive. Pathogens cannot synthesize cholesterol, and salvaging host cholesterol helps pathogens build advanced cholesterol-containing membranes and assembly platforms. Impact on cholesterol metabolism is not limited to the infected cells; proteins and microRNAs secreted by infected cells affect lipid metabolism systemically. SUMMARY: Given an essential role that host cholesterol metabolism plays in pathogen development, targeting this interaction may be a viable strategy to fight infections, as well as metabolic complications of the infections.
PURPOSE OF REVIEW: Pathogens of different taxa, from prions to protozoa, target cellular cholesterol metabolism to advance their own development and to impair host immune responses, but also causing metabolic complications, for example, atherosclerosis. This review describes recent findings of how pathogens do it. RECENT FINDINGS: A common theme in interaction between pathogens and host cholesterol metabolism is pathogens targeting lipid rafts of the host plasma membrane. Many intracellular pathogens use rafts as an entry gate, taking advantage of the endocytic machinery and high abundance of outward-looking molecules that can be used as receptors. At the same time, disruption of the rafts' functional capacity, achieved by the pathogens through a number of various means, impairs the ability of the host to generate immune response, thus helping pathogen to thrive. Pathogens cannot synthesize cholesterol, and salvaging host cholesterol helps pathogens build advanced cholesterol-containing membranes and assembly platforms. Impact on cholesterol metabolism is not limited to the infected cells; proteins and microRNAs secreted by infected cells affect lipid metabolism systemically. SUMMARY: Given an essential role that host cholesterol metabolism plays in pathogen development, targeting this interaction may be a viable strategy to fight infections, as well as metabolic complications of the infections.
Authors: Bela F Asztalos; Zahedi Mujawar; Matthew P Morrow; Angela Grant; Tatiana Pushkarsky; Christine Wanke; Richard Shannon; Matthias Geyer; Frank Kirchhoff; Dmitri Sviridov; Michael L Fitzgerald; Michael Bukrinsky; Keith G Mansfield Journal: J Infect Dis Date: 2010-08-15 Impact factor: 5.226
Authors: Hann Low; Nigora Mukhamedova; Huanhuan L Cui; Brian P McSharry; Selmir Avdic; Anh Hoang; Michael Ditiatkovski; Yingying Liu; Ying Fu; Peter J Meikle; Martin Blomberg; Konstantinos A Polyzos; William E Miller; Piotr Religa; Michael Bukrinsky; Cecilia Soderberg-Naucler; Barry Slobedman; Dmitri Sviridov Journal: Cell Rep Date: 2016-06-16 Impact factor: 9.423
Authors: Mark H Kuniholm; Hua Liang; Kathryn Anastos; Deborah Gustafson; Seble Kassaye; Marek Nowicki; Beverly E Sha; Emilia J Pawlowski; Stephen J Gange; Bradley E Aouizerat; Tatiana Pushkarsky; Michael I Bukrinsky; Vinayaka R Prasad Journal: AIDS Date: 2017-11-28 Impact factor: 4.632
Authors: Amanda M Casto; Sachiko Seo; David M Levine; Barry E Storer; Xinyuan Dong; John A Hansen; Michael Boeckh; Paul J Martin Journal: Blood Date: 2021-10-28 Impact factor: 25.476